Works matching IS 02704137 AND DT 2006 AND VI 66 AND IP 11

Results: 10

Overexpression of EIF3S3 promotes cancer cell growth.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1144, doi. 10.1002/pros.20452

By:

Kimmo J. Savinainen;
Merja A. Helenius;
Heli J. Lehtonen;
Tapio Visakorpi

Publication type:

Article

A histone deacetylation‐dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1151, doi. 10.1002/pros.20451

By:

Maite Hernandez;
Qing Shao;
Xiang‐Jiao Yang;
Shi‐Ping Luh;
Mustapha Kandouz;
Gerald Batist;
Dale W. Laird;
Moulay A. Alaoui‐Jamali

Publication type:

Article

Androgen and anti‐androgen treatment modulates androgen receptor activity and DJ‐1 stabilityTiina Pitkänen‐Arsiola and J. Erin Tillman have contributed equally to this work.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1177

By:

Tiina Pitkänen‐Arsiola;
J. Erin Tillman;
Guangyu Gu;
Jialing Yuan;
Richard L. Roberts;
Marcus Wantroba;
Gerhard A. Coetzee;
Michael S. Cookson;
Susan Kasper

Publication type:

Article

The North Carolina–Louisiana Prostate Cancer Project (PCaP): Methods and design of a multidisciplinary population‐based cohort study of racial differences in prostate cancer outcomesFirst authorship shared by Dr. Schroeder and Dr. Bensen.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1162, doi. 10.1002/pros.20449

By:

Jane C. Schroeder;
Jeannette T. Bensen;
L. Joseph Su;
Merle Mishel;
Anastasia Ivanova;
Gary J. Smith;
Paul A. Godley;
Elizabeth T. H. Fontham;
James L. Mohler

Publication type:

Article

Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1194, doi. 10.1002/pros.20444

By:

M. Tandy Sutton;
Melissa Yingling;
Ash Vyas;
Humphrey Atiemo;
Andrew Borkowski;
Stephen C. Jacobs;
Natasha Kyprianou

Publication type:

Article

Genistein‐induced neuroendocrine differentiation of prostate cancer cells.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1136, doi. 10.1002/pros.20440

By:

Jacek Pinski;
Qingcai Wang;
Marcus L. Quek;
Ariana Cole;
Janine Cooc;
Kathleen Danenberg;
Peter V. Danenberg

Publication type:

Article

Protein tyrosine phosphatase PTP1B is involved in neuroendocrine differentiation of prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1125, doi. 10.1002/pros.20412

By:

Chengyu Wu;
Li Zhang;
Patricia A. Bourne;
Jay E. Reeder;
P. Anthony di Sant'Agnese;
Jorge L. Yao;
Yanqun Na;
Jiaoti Huang

Publication type:

Article

Expression of mTOR signaling pathway markers in prostate cancer progression.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1203, doi. 10.1002/pros.20410

By:

Celeste L. Kremer;
Rob R. Klein;
Jenny Mendelson;
Walden Browne;
Linda K. Samadzedeh;
Kristie Vanpatten;
Lindsey Highstrom;
Gary A. Pestano;
Raymond B. Nagle

Publication type:

Article

New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1213, doi. 10.1002/pros.20408

By:

Bruce E. LeRoy;
Nanda K. Thudi;
Murali V.P. Nadella;
Ramiro E. Toribio;
Sarah H. Tannehill‐Gregg;
Adrie van Bokhoven;
Deborah Davis;
Stephanie Corn;
Thomas J. Rosol

Publication type:

Article

NF‐κB activation upregulates fibroblast growth factor 8 expression in prostate cancer cellsThe authors have no disclosures to make.

Published in:

Prostate, 2006, v. 66, n. 11, p. 1223, doi. 10.1002/pros.20376

By:

Kelly Armstrong;
Craig N. Robson;
Hing Y. Leung

Publication type:

Article